|
|
(30 intermediate revisions not shown) |
Line 1: |
Line 1: |
- | <b> MAX!!!! mach mich voll!!! | + | <html xmlns="http://www.w3.org/1999/xhtml" dir="ltr" |
| + | lang="en-US"> |
| + | <head> |
| + | <meta content="text/html; charset=UTF-8" |
| + | http-equiv="Content-Type" /> |
| + | <meta content="IE=EmulateIE7" http-equiv="X-UA-Compatible" /> |
| + | <title>FREiGEM</title> |
| + | <script src="script.js" type="text/javascript"></script> |
| + | <link media="screen" type="text/css" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css" |
| + | rel="stylesheet" /> |
| + | <!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]--> |
| + | </head> |
| + | <body> |
| + | <div id="art-page-background-simple-gradient"> </div> |
| + | <div id="art-main"> |
| + | <div class="art-Sheet"> |
| + | <div class="art-Sheet-tl"></div> |
| + | <div class="art-Sheet-tr"></div> |
| + | <div class="art-Sheet-bl"></div> |
| + | <div class="art-Sheet-br"></div> |
| + | <div class="art-Sheet-tc"></div> |
| + | <div class="art-Sheet-bc"></div> |
| + | <div class="art-Sheet-cl"></div> |
| + | <div class="art-Sheet-cr"></div> |
| + | <div class="art-Sheet-cc"></div> |
| + | <div class="art-Sheet-body"> |
| + | <div class="art-Header"> |
| + | <div class="art-Header-jpeg"></div> |
| + | </div> |
| + | <div class="art-nav"> |
| + | <div class="l"></div> |
| + | <div class="r"></div> |
| + | <ul class="art-menu"> |
| + | <li><a href="https://2009.igem.org/Team:Freiburg_bioware"><span |
| + | class="l"></span><span class="r"></span><span |
| + | class="t">Home</span></a></li> |
| + | <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span |
| + | class="l"></span><span class="r"></span><span |
| + | class="t">The Team</span></a> |
| + | <ul> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Team">Overview</a></li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Team/Portraits">Portraits</a></li> |
| + | </ul> |
| + | </li> |
| + | <li><a class="active" |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span |
| + | class="l"></span><span class="r"></span><span |
| + | class="t">The |
| + | Project</span></a> |
| + | <ul> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a> |
| + | </li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Subprojects">Subprojects</a></li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li> |
| + | </ul> |
| + | </li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice"><span |
| + | class="l"></span><span class="r"></span><span |
| + | class="t">Human |
| + | Practice</span></a> |
| + | <ul> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Ethics">Ethics</a> |
| + | </li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Safety">Safety</a></li> |
| + | </ul> |
| + | </li> |
| + | <li><a href="#"><span class="l"></span><span |
| + | class="r"></span><span class="t">Notebook</span></a></li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span |
| + | class="l"></span><span class="r"></span><span |
| + | class="t">Parts</span></a> |
| + | <ul> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/cloning1">Basic |
| + | Parts</a></li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/cloning">Composite |
| + | Parts</a></li> |
| + | </ul> |
| + | </li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Collaboration"><span |
| + | class="l"></span><span class="r"></span><span |
| + | class="t">Collaboration</span></a></li> |
| + | <li><a |
| + | href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span |
| + | class="l"></span><span class="r"></span><span |
| + | class="t">Modeling</span></a> </li> |
| + | </ul> |
| + | </div> |
| + | <div class="art-contentLayout"> |
| + | <div class="art-content"> |
| + | <div class="art-Post"> |
| + | <div class="art-Post-tl"></div> |
| + | <div class="art-Post-tr"></div> |
| + | <div class="art-Post-bl"></div> |
| + | <div class="art-Post-br"></div> |
| + | <div class="art-Post-tc"></div> |
| + | <div class="art-Post-bc"></div> |
| + | <div class="art-Post-cl"></div> |
| + | <div class="art-Post-cr"></div> |
| + | <div class="art-Post-cc"></div> |
| + | <div class="art-Post-body"> |
| + | <div class="art-Post-inner"> |
| + | <div class="art-PostMetadataHeader"> |
| + | <h2 class="art-PostHeaderIcon-wrapper"> <img |
| + | style="width: 28px; height: 25px;" alt="" |
| + | src="https://static.igem.org/mediawiki/2009/2/2a/Freiburg09_Post_tanne_2.png" /> |
| + | Fok Monomer<span class="art-PostHeader"></span> </h2> |
| + | </div> |
| + | <div class="art-PostContent"> |
| + | <div style="text-align: left;"> |
| + | <p class="MsoNormal" style="text-align: justify;"><b |
| + | style=""><u>Introduction<o:p></o:p></u></b> |
| + | <p class="MsoNormal" style="text-align: justify;"><o:p> </o:p></p></div> |
| + | <p style="text-align: justify;"><span |
| + | style="" lang="EN-GB">In order to create a universal |
| + | restriction |
| + | enzyme, we followed several ideas and models. The first and most |
| + | promising idea |
| + | we had was to create a monomeric restriction enzyme as it represents the optimal and |
| + | easiest |
| + | model for a universal restriction enzyme<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><u><span |
| + | style="" lang="EN-GB"><o:p><span |
| + | style="text-decoration: none;"></span></o:p></span></u><span |
| + | style="" lang="EN-GB">If we are able to employ a |
| + | monomeric enzyme, |
| + | this protein would have a couple of advantages: Most importantly we |
| + | would no longer |
| + | need two separate oligonucleotides to achieve specific binding and |
| + | cleavage of |
| + | the target DNA. Also, only one protein has to be purified – |
| + | thus saving time and |
| + | money. A scientific advantage is the option to optimize the monomer by |
| + | phage |
| + | display. Using this technology, we would have the chance to create a |
| + | thermostable, specific, universal restriction enzyme whose DNA binding |
| + | specificity |
| + | is simply created by a single oligonucleotide.<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><u><span |
| + | style="" lang="EN-GB"><o:p><span |
| + | style="text-decoration: none;"></span></o:p></span></u><span |
| + | style="" lang="EN-GB">Our goal was first, to create |
| + | a Fok-monomer that |
| + | is able to cut DNA without a primary dimerization step, and second, to |
| + | show |
| + | that our heterodimeric interface design works properly. To reach this, |
| + | we had |
| + | to clone all the required parts one after another, resulting in a huge |
| + | fusion |
| + | protein.<o:p><br /> |
| + | </o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><o:p></b><br /> |
| + | </o:p></span><b style=""><u><span |
| + | style="" lang="EN-GB">Results<o:p></o:p></span></u></b></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><u><span |
| + | style="" lang="EN-GB">3D modeling and design goals<o:p></o:p></span></u></p></b> |
| + | <p class="MsoNormal" style="text-align: justify;"></p> |
| + | <table style="text-align: left; width: 208px; height: 225px;" |
| + | border="1" cellpadding="0" cellspacing="0"> |
| + | <tbody> |
| + | <tr> |
| + | <td><img style="width: 600px; height: 300px;" |
| + | alt="" |
| + | src="https://static.igem.org/mediawiki/2009/2/29/Freiburg09_Monomermodel1.JPG" /></td> |
| + | </tr> |
| + | <tr> |
| + | <td><span style="font-size: 10pt;" lang="EN-GB">Fig. 1: |
| + | <st1:place w:st="on"><st2:Sn w:st="on">Scheme of monomoeric Fok:</st2:Sn> |
| + | <st2:Sn w:st="on">I.</st2:Sn></st1:place> |
| + | lipocalin,<span style=""> </span>II. |
| + | Foka/Foki (heterodimers), III. |
| + | Linker,<span style=""> </span>IV. His-Tag</span></td> |
| + | </tr> |
| + | </tbody> |
| + | </table> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><o:p></o:p></span><span |
| + | style="font-size: 10pt;" lang="EN-GB"></span><span |
| + | style="" lang="EN-US">The necessary parts in the |
| + | model of a |
| + | monomeric restriction enzyme are: Tag-binding protein (lipocalin) - Fok |
| + | heterodimer1 - |
| + | linker - Fok heterodimer2 (Fig. 1). <o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="font-size: 10pt;" lang="EN-US"><o:p> </o:p></span><span |
| + | style="font-size: 10pt;" lang="EN-US"><o:p> |
| + | <table style="text-align: left; width: 705px; height: 50px;" |
| + | border="1" cellpadding="0" cellspacing="0"> |
| + | <tbody> |
| + | <tr> |
| + | <td style="text-align: center;">Tag</td> |
| + | <td style="text-align: center;">binding protein</td> |
| + | <td style="text-align: center;">linker</td> |
| + | <td style="text-align: center;">Fok heterodimer</td> |
| + | </tr> |
| + | <tr> |
| + | <td style="text-align: left;" valign="top"> |
| + | HisTag (BBa_K157011)<br> |
| + | StrepTag(BBa_K157012) |
| + | </td> |
| + | <td style="text-align: left;" valign="top"> |
| + | FluA(BBa_K157004)<br> |
| + | DigA(BBa_K243003)<br> |
| + | Fos(BBa_K243027) |
| + | </td> |
| + | <td style="text-align: left;" valign="top"> |
| + | GSAT-Linker(BBa_K243029)<br> |
| + | SEGLinker(BBa_K243030) |
| + | </td> |
| + | <td style="text-align: left;" valign="top"> |
| + | FokA (K243000)<br> |
| + | Foki (K243001) |
| + | </td> |
| + | </tr> |
| + | </tbody> |
| + | </table> |
| + | </o:p></span><span style="font-size: 10pt;" |
| + | lang="EN-US"><o:p></o:p></span><span |
| + | style="font-size: 9pt;" lang="EN-US">Tab. 1: List of |
| + | parts usable for |
| + | Fok Monomer<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="font-size: 9pt;" lang="EN-US"><o:p></o:p></span><span |
| + | style="" lang="EN-US">In order to purify this fusion |
| + | protein, we employed an N-terminal tag. The binding protein (a lipocalin-derived binding protein referred to as anticalin in analogy to antibodies) mediates |
| + | between the |
| + | FokI protein and the tagged oligonucleotide</span><span style="" |
| + | lang="EN-GB">. Both parts of the Fok heterodimers are |
| + | associated with a long flexible linker allowing |
| + | them to establish the cutting site conformation. This artificial |
| + | restriction |
| + | nuclease domain is the functional part of the monomer and catalyzes the |
| + | DNA |
| + | cleavage.<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><o:p></o:p>Before |
| + | we started in the wet lab, we thoroughly planned all |
| + | the individual steps. To figure out the best way to create the Fok |
| + | monomer, we first designed it <i style="">in |
| + | silico.<o:p></o:p></i></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><span style=""></span></span></p> |
| + | <table style="text-align: left; width: 196px; height: 225px;" |
| + | border="1" cellpadding="0" cellspacing="0"> |
| + | <tbody> |
| + | <tr> |
| + | <td><span style="" lang="EN-GB"><img |
| + | style="width: 600px; height: 400px;" alt="" |
| + | src="https://static.igem.org/mediawiki/2009/1/15/Freiburg09_model1.png" /><br /> |
| + | </span> |
| + | </td> |
| + | </tr> |
| + | <tr> |
| + | <td><span style="font-size: 10pt;" lang="EN-GB">Fig. 2: |
| + | 3D model of Fok Monomer</span></td> |
| + | </tr> |
| + | </tbody> |
| + | </table> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB">The model (Fig. 2) shows that we |
| + | have to use a |
| + | linker which is about 70 Angstrom in length to |
| + | span the required |
| + | distance between the two Fok parts. Therefore, we decided to order two |
| + | complementary oligonucleotides encoding a 36 amino acid long glycine-serine |
| + | linker.<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="display:block; width:100%; overflow:scroll;" lang="EN-GB"><o:p> </o:p> |
| + | 5'-CTAGATGGCCGGCGGTTCTGGTGGTGGTTCTGGCGGTGGTTCTGGAGGTAGTTCTGGCGGTGGATCTGGAGGCGGTTCTGGGTCAGGATCTGGTG<b |
| + | style=""><span style="color: lime;">GA</span></b>GGTTCTGGCTCTGGGAATCAGA-3'</br> |
| + | 3'-TACCGGCCGCCAAGACCACCACCAAGACCGCCACCAAGACCTCCATCAAGACCGCCACCTAGACCTCCGCCAAGACCCAGTCCTAGACCAC<b |
| + | style=""><span style="color: lime;">TA</span></b>CCAAGACCGAGACCCTTAGTCTGGCC-5<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><o:p></o:p><span |
| + | style="text-decoration: underline;"></span></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><span |
| + | style="text-decoration: underline;">Cloning</span></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB">However, at this stage the first |
| + | problem |
| + | appeared.<o:p></o:p> These are the oligonucleotides, each |
| + | 120 nt long, which we ordered from Mr.Gene. Unfortunately, we made a mistake when |
| + | ordering the |
| + | complementary oligonucleotide. Accidentally we introduced two mismatches |
| + | (compare |
| + | colored bases in the sequence). But somehow we managed to dimerize the |
| + | two |
| + | oligonucleotides.<o:p></o:p> After dimerization in the thermocycler |
| + | and |
| + | cloning into a pMA (BBa_K243031) vector (XbaI/AgeI) some mutations |
| + | appeared in |
| + | the 36GSLinker gene caused by the mismatches. As there was no |
| + | frame |
| + | shift we decided to carry on. <o:p></o:p><br /> |
| + | First, we picked the parts we were going to |
| + | use. We decided to use one we already completed in our earlier |
| + | experiments: His |
| + | – FluA – <st1:place w:st="on"><st1:City |
| + | w:st="on">Split</st1:City></st1:place> - |
| + | Foki (BBa_K243010) had all the functions we needed. These are (i) a purification tag, |
| + | (ii) a Fok domain and (iii) the anticalin that binds the |
| + | tagged |
| + | oligonucleotide (Fig. 1). Cloning the linker (no part) behind these parts was |
| + | the next |
| + | step. We followed the assembly standard 25 and opened the vector with AgeI |
| + | and |
| + | PstI and cut the inserted with NgoMIV and PstI.<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><o:p> |
| + | <table style="text-align: left; width: 217px; height: 249px;" |
| + | border="1" cellpadding="0" cellspacing="0"> |
| + | <tbody> |
| + | <tr> |
| + | <td><img style="width: 490px; height: 400px;" |
| + | alt="" |
| + | src="https://static.igem.org/mediawiki/2009/thumb/b/bd/Freiburg09_TestverdauFokM1.JPG/792px-Freiburg09_TestverdauFokM1.JPG" /></td> |
| + | </tr> |
| + | <tr> |
| + | <td> |
| + | <p class="MsoNormal"><span |
| + | style="font-size: 10pt;" lang="EN-GB">Fig. 3: Gel |
| + | picture of test digest<o:p></o:p></span></p> |
| + | </td> |
| + | </tr> |
| + | </tbody> |
| + | </table> |
| + | </o:p><br /> |
| + | However, we ran into some more problems. After cloning Foka |
| + | (BBa_K243000) after the other parts, again assembly standard 25, we |
| + | performed test restriction digests cutting out the insert to confirm its size. These digests showed that the |
| + | plasmid |
| + | became even smaller as it would be without an insertion (pEX: ~ 4,5kbp |
| + | and after |
| + | test digestion ~ 2,2kbp). The insert should have a size of about 1.9 kbp but was found to be only about 900 bp (Fig. 3). <span style=""> </span>The sequencing did not work either.<o:p><br /> |
| + | </o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB">Most likely, the active Fok did |
| + | cut the plasmid |
| + | and promoted deletion of the Fok gene, which gave such mutated cells a |
| + | significant |
| + | growth advantage. After we encountered these problems, we decided to order the 36GS-linker (GSAT |
| + | Linker: |
| + | BBa_K243029) as gene synthesis.<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><o:p> </o:p>5´-GAGCTCGAATTCGCGGCCGCTTCTAGATGGCCGGCGGTGGTTCTGCCGGT<o:p></o:p>GGCTCCGGTTCTGGCTCCAGCGGTGGCAGCTCTGGTGCGTCCGGCACGGG<o:p></o:p><br /> |
| + | TACTGCGGGTGGCACTGGCAGCGGTTCCGGTACTGGCTCTGGCACCGGTA<o:p></o:p>ATACTAGTAGCGGCCGCTGCAGGGTACC-3´<o:p></o:p></span></p> |
| + | <p class="MsoNormal" style="text-align: justify;"><span |
| + | style="" lang="EN-GB"><o:p></o:p>This |
| + | time the order was well planned but, unfortunately, it |
| + | took over 4 weeks for the synthesis and delivery, and the genes arrived too |
| + | late. Once |
| + | again we have to make all the cloning steps. As of mid October 2009, the |
| + | project |
| + | is still in progress.<o:p></o:p></span></p> |
| + | </div> |
| + | <br /> |
| + | <div style="text-align: center;"> |
| + | </div> |
| + | <br /> |
| + | </div> |
| + | <div class="cleared"></div> |
| + | </div> |
| + | </div> |
| + | </div> |
| + | <br /> |
| + | </div> |
| + | </div> |
| + | <div class="cleared"></div> |
| + | <div class="art-Footer"> |
| + | <div class="art-Footer-inner"> |
| + | <div class="art-Footer-text"> |
| + | <p>contact: <a |
| + | href="mailto:freigem09@googlemail.com">freigem09@googlemail.com</a><br /> |
| + | </p> |
| + | </div> |
| + | </div> |
| + | <div class="art-Footer-background"></div> |
| + | </div> |
| + | </div> |
| + | </div> |
| + | </div> |
| + | </body> |
| + | </html> |